Peat, J.K., Woolcock, A.J., Cullen, K., Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 70 (1987), 171–179.
Lange, P., Parner, J., Vestbo, J., Schnohr, P., Jensen, G., A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339 (1998), 1194–1200.
Graff, S., Demarche, S., Henket, M., Paulus, V., Louis, R., Schleich, F., Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma. Respir. Med., 2019, 60–66.
Bai, T.R., Knight, D.A., Structural changes in the airways in asthma: observations and consequences. Clin. Sci. 108 (2005), 463–477.
Fehrenbach, H., Wagner, C., Wegmann, M., Airway remodeling in asthma: what really matters. Cell Tissue Res. 367 (2017), 551–569.
Hudson, C., Turcotte, H., Laviolette, M., Carrier, G., Boulet, L.-P., Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann. Allergy Asthma Immunol. 78 (1997), 195–202.
Panhuysen, C.I., Vonk, J.M., Koëter, G.H., Schouten, J.P., van Altena, R., Bleecker, E.R., Postma, D.S., Adult patients may outgrow their asthma: a 25-year follow-up study. Am. J. Respir. Crit. Care Med. 155:4 (1997 Apr), 1267–1272, 10.1164/ajrccm.155.4.9105065 PubMed PMID: 9105065.
Ulrik, C.S., Backer, V., Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur. Respir. J. 14 (1999), 892–896.
Zhang, L., He, L., Gong, J., Liu, C., Risk factors associated with irreversible airway obstruction in asthma: a systematic review and meta-analysis. Biomed. Res. Int., 2016 2016Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828538/.
Bumbacea, D., Campbell, D., Nguyen, L., Carr, D., Barnes, P.J., Robinson, D., Chung, K.F., Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur. Respir. J. 24 (2004), 122–128.
Sexton, P., Black, P., Wu, L., Sommerville, F., Hamed, M., Metcalf, P., Kolbe, J., Fixed airflow obstruction among nonsmokers with asthma:A case-comparison study. J. Asthma 50 (2013), 606–612.
Lee, J.H., Haselkorn, T., Borish, L., Rasouliyan, L., Chipps, B.E., Wenzel, S.E., Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest 132 (2007), 1882–1889.
Mascia, K., Haselkorn, T., Deniz, Y.M., Miller, D.P., Bleecker, E.R., Borish, L., Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J. Allergy Clin. Immunol. 116 (2005), 970–975.
ten Brinke, A., Zwinderman, A.H., Sterk, P.J., Rabe, K.F., Bel, E.H., Factors associated with persistent airflow limitation in severe asthma. Am. J. Respir. Crit. Care Med. 164 (2001), 744–748.
Jang, A.-S., Park, J.-S., Lee, J.-H., Park, S.-W., Kim, D.-J., Uh, S.-T., Kim, Y.-H., Park, C.-S., Asthmatics without rhinitis have more fixed airway obstruction than those with concurrent rhinitis. Allergy Asthma Immunol. Res., 2, 2010, 108.
Jeffery, P.K., Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1 (2004), 176–183.
Hogg, J.C., Chu, F., Utokaparch, S., Woods, R., Elliott, W.M., Buzatu, L., Cherniack, R.M., Rogers, R.M., Sciurba, F.C., Coxson, H.O., Paré, P.D., The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350 (2004), 2645–2653.
Chung, K.F., Adcock, I.M., Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31 (2008), 1334–1356.
Godinas, L., Corhay, J.-L., Henket, M., Guiot, J., Louis, R., Moermans, C., Increased production of TGF-β1 from sputum cells of COPD: relationship with airway obstruction. Cytokine 99 (2017), 1–8.
Juniper, E.F., Guyatt, G.H., Epstein, R.S., Ferrie, P.J., Jaeschke, R., Hiller, T.K., Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47 (1992), 76–83.
Juniper, E.F., O′ byrne, P.M., Guyatt, G.H., Ferrie, P.J., King, D.R., Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 14 (1999), 902–907.
Schatz, M., Sorkness, C.A., Li, J.T., Marcus, P., Murray, J.J., Nathan, R.A., Kosinski, M., Pendergraft, T.B., Jhingran, P., Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J. Allergy Clin. Immunol. 117 (2006), 549–556.
Dweik, R.A., Boggs, P.B., Erzurum, S.C., Irvin, C.G., Leigh, M.W., Olin, A.-C., Plummer, A.L., Taylor, R.D., An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 184 (2011), 602–615.
Guiot, J., Demarche, S., Henket, M., Paulus, V., Graff, S., Schleich, F., Corhay, J.-L., Louis, R., Moermans, C., Methodology for sputum induction and laboratory processing. Journal of Visualized Experiments, 2019 [Internet] 2017 [cited 2019 Dec 9]; Available from: https://www.jove.com/video/56612/methodology-for-sputum-induction-and-laboratory-processing.
Louis, R., Godinas, L., Schleich, F., Induced Sputum - towards Normal Values, Non Invasive Assessment of Airways Inflammation in Asthma and COPD. 14th, Tetrapoleos Street, 115 27, 2011, Paschalidis Medical Publications, Athens Greece.
Contoli, M., Baraldo, S., Marku, B., Casolari, P., Marwick, J.A., Turato, G., Romagnoli, M., Caramori, G., Saetta, M., Fabbri, L.M., Papi, A., Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J. Allergy Clin. Immunol. 125 (2010), 830–837.
COhort for Reality and Evolution of adult Asthma in Korea study group (COREA study group), Lee, T., Lee, Y.S., Bae, Y.-J., Kim, T.-B., Kim, S.O., Cho, S.-H., Moon, H.-B., Cho, Y.S., Smoking, longer disease duration and absence of rhinosinusitis are related to fixed airway obstruction in Koreans with severe asthma: findings from the COREA study. Respir. Res., 12, 2011, 1.
Heijink, I.H., Pouwels, S.D., Leijendekker, C., de Bruin, H.G., Zijlstra, G.J., van der Vaart, H., ten Hacken, N.H.T., van Oosterhout, A.J.M., Nawijn, M.C., van der Toorn, M., Cigarette smoke–induced damage-associated molecular pattern release from necrotic neutrophils triggers proinflammatory mediator release. Am. J. Respir. Cell Mol. Biol. 52 (2015), 554–562.
Huang, X., Tan, X., Liang, Y., Hou, C., Qu, D., Li, M., Huang, Q., Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients. Sci. Rep., 9, 2019, 19241.
Thomson, N.C., Asthma and cigarette smoking. Eur. Respir. J. 24 (2004), 822–833.
Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., Adcock, I.M., Bateman, E.D., Bel, E.H., Bleecker, E.R., Boulet, L.-P., Brightling, C., Chanez, P., Dahlen, S.-E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jajour, N.N., Mauad, T., Sorkness, R.L., Teague, W.G., International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. 43 (2014), 343–373.
Schleich, F., Brusselle, G., Louis, R., Vandenplas, O., Michils, A., Pilette, C., Peche, R., Manise, M., Joos, G., Heterogeneity of phenotypes in severe asthmatics. The Belgian severe asthma registry (BSAR). Respir. Med. 108 (2014), 1723–1732.
Kariyawasam, H.H., Robinson, D.S., The role of eosinophils in airway tissue remodelling in asthma. Curr. Opin. Immunol. 19 (2007), 681–686.
Schleich, F.N., Manise, M., Sele, J., Henket, M., Seidel, L., Louis, R., Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm. Med., 13, 2013, 11.
Schleich, F.N., Chevremont, A., Paulus, V., Henket, M., Manise, M., Seidel, L., Louis, R., Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur. Respir. J. 44 (2014), 97–108.
Schleich, F., Graff, S., Nekoee, H., Moermans, C., Henket, M., Sanchez, C., Paulus, V., Guissard, F., Donneau, A., Louis, R., Real‐word experience with mepolizumab: does it deliver what it has promised?. Clin. Exp. Allergy 50 (2020), 687–695.
Cianchetti, S., Cardini, C., Puxeddu, I., Latorre, M., Bartoli, M.L., Bradicich, M., Dente, F., Bacci, E., Celi, A., Paggiaro, P., Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction. World Allergy Org. J., 12, 2019, 100078.
Flood-Page, P.T., Menzies-Gow, A.N., Kay, A.B., Robinson, D.S., Eosinophil's role remains uncertain as anti–interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167 (2003), 199–204.
Wakefield, L.M., Winokur, T.S., Hollands, R.S., Christopherson, K., Levinson, A.D., Sporn, M.B., Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J. Clin. Invest. 86 (1990), 1976–1984.
Demarche, S., Schleich, F., Henket, M., Paulus, V., Louis, R., Van Hees, T., Step-down of inhaled corticosteroids in non-eosinophilic asthma: a prospective trial in real life. Clin. Exp. Allergy 48 (2018), 525–535.
Liebhart, J., Polak, M., Dabrowski, A., Dobek, R., Liebhart, E., Dor-Wojnarowska, A., Barg, W., Kulczak, A., Medrala, W., Gladysz, U., Lange, A., The G/G genotype of transforming growth factor beta 1 (TGF-β1) single nucleotide (+915G/C) polymorphism coincident with other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics. Int. J. Immunogenet. 35 (2008), 417–422.
Haldar, P., Pavord, I.D., Shaw, D.E., Berry, M.A., Thomas, M., Brightling, C.E., Wardlaw, A.J., Green, R.H., Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 178 (2008), 218–224.
BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 52 (1997), 1–28.
National Institute for Clinical Excellence. Clinical Guideline 12. Chronic Obstructive Pulmonary Disease February 2004. accessed www.nice.org.uk/CG012NICEguideline. (Accessed 3 October 2008)
Swanney, M.P., Ruppel, G., Enright, P.L., Pedersen, O.F., Crapo, R.O., Miller, M.R., Jensen, R.L., Falaschetti, E., Schouten, J.P., Hankinson, J.L., Stocks, J., Quanjer, P.H., Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 63 (2008), 1046–1051.
